10:19 AM EST - Fennec Pharmaceuticals Inc. : reported its financial results for the first quarter ended March 31, 2015. The company reported net income of $177,000 U.S., in contrast with a loss of $3.1 million U.S. in the prior-year quarter. Fennec Pharmaceuticals Inc.
shares T.FRX are trading unchanged at $2.50.
